ANOVA summary table for depression. by Ben Carey (9962347)

Subjects:

Genes whose transcript abundance decreased less than half after exposure to N₂O₅ gas compared to air control in RNA-seq analysis. by Daiki Tsukidate (12936828)

Scores, change in the measures of interest, and <i>p</i>-values for binomial tests of significance in change in scores before and since the pandemic began. by Stacey Giroux (13607651)

Subjects:

Meta-analysis of odds ratio between perinatal depression and underweight (n = 10)–subgroup analysis according to region and type of perinatal depression (antepartum vs. by Elizabeth Carosella (19959424)

Subjects:

Baseline participant characteristics also disaggregated by depressive symptoms status. by Katrina A. Obas (15198148)

Subjects:

Distribution of students in the depression and stress groups. by Upama Chowdhury (12407383)

Subjects:

Patient-reported outcome measures. by Simon Gilbody (52503)

Demographic characteristics of the subjects. by Jiro Masuya (8881856)

Subjects:

Pearson’s correlation coefficients (<i>r</i>) among age, CATS total scores, EPQ-R scores, PHQ-9 scores, and PSQI-J total scores of the subjects. by Jiro Masuya (8881856)

Subjects:

Conditional indirect effects of CATS total scores on PHQ-9 scores through EPQ-R across levels of PSQI-J global scores. by Jiro Masuya (8881856)

Subjects:

Moderated mediation model of sleep disturbance, childhood maltreatment, neuroticism and depressive symptoms. by Jiro Masuya (8881856)

Subjects:

This is the data set that we used to reach the conclusions drawn in the manuscript with related metadata and methods. by Farayi Kaseke (19560197)

Screening Sheet: A sheet that contains the full screening process that we used to include or exclude any study. by Mohamed R. Abdelraouf (21501468)

Demographic and clinical characteristics. by Samuel Alldritt (22097240)

Subjects:

Raw data. by Samuel Alldritt (22097240)

Subjects:

Regression plot showing how effort discounting <i>k</i> increases linearly (Spearman <i>rho</i>) with reported CLBP intensity. by Samuel Alldritt (22097240)

Subjects:

Plots showing the adjusted average ± SEM proportion of HC/HR choices (y-axis) on the first 50 trials of the EEfRT as a function of probability levels (A) and reward magnitudes (B)... by Samuel Alldritt (22097240)

Subjects:

Image1_Country-specific psychopharmacological risk of reporting suicidality comparing 38 antidepressants and lithium from the FDA Adverse Event Reporting System, 2017–2023.pdf by Andy Roger Eugene (20028012)

Image1_Country-specific psychopharmacological risk of reporting suicidality comparing 38 antidepressants and lithium comparing the FDA Adverse Event Reporting System, 2017–2023.pdf... by Andy Roger Eugene (20028012)

Table1_Country-specific psychopharmacological risk of reporting suicidality comparing 38 antidepressants and lithium from the FDA Adverse Event Reporting System, 2017–2023.docx by Andy Roger Eugene (20028012)